Anti‐laminin‐332 mucous membrane pemphigoid with autoantibodies to α3, β3 and γ2 subunits of laminin‐332 as well as to BP 230 and periplakin associated with adenocarcinoma from an unknown primary site
2012; Wiley; Volume: 40; Issue: 1 Linguagem: Inglês
10.1111/j.1346-8138.2012.01645.x
ISSN1346-8138
AutoresOsamu Fukuchi, Ayana Suko, Hiroyuki Matsuzaki, Hiromi Baba, Hisatoshi Yoshida, Tsunemichi Takeuchi, Syunichi Odawara, Shunpei Fukuda, Takashi Hashimoto,
Tópico(s)Urticaria and Related Conditions
ResumoThe Journal of DermatologyVolume 40, Issue 1 p. 61-62 Letters to the Editor Anti-laminin-332 mucous membrane pemphigoid with autoantibodies to α3, β3 and γ2 subunits of laminin-332 as well as to BP230 and periplakin associated with adenocarcinoma from an unknown primary site Osamu Fukuchi, Osamu Fukuchi Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorAyana Suko, Ayana Suko Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorHiroyuki Matsuzaki, Hiroyuki Matsuzaki Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorHiromi Baba, Hiromi Baba Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorHisatoshi Yoshida, Hisatoshi Yoshida Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorTsunemichi Takeuchi, Corresponding Author Tsunemichi Takeuchi Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanCorrespondence: Tsunemichi Takeuchi, M.D., Section of Dermatology, Kawasakisaiwai Clinic, 1-27-1 Minamisaiwai-cyo, Saiwai-ku, Kawasaki-shi, Kanagawa 212-0016, Japan. Email. [email protected]Search for more papers by this authorSyunichi Odawara, Syunichi Odawara Departments of Gastroenterology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorShunpei Fukuda, Shunpei Fukuda Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Fukuoka, JapanSearch for more papers by this authorTakashi Hashimoto, Takashi Hashimoto Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Fukuoka, JapanSearch for more papers by this author Osamu Fukuchi, Osamu Fukuchi Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorAyana Suko, Ayana Suko Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorHiroyuki Matsuzaki, Hiroyuki Matsuzaki Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorHiromi Baba, Hiromi Baba Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorHisatoshi Yoshida, Hisatoshi Yoshida Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorTsunemichi Takeuchi, Corresponding Author Tsunemichi Takeuchi Departments of Dermatology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanCorrespondence: Tsunemichi Takeuchi, M.D., Section of Dermatology, Kawasakisaiwai Clinic, 1-27-1 Minamisaiwai-cyo, Saiwai-ku, Kawasaki-shi, Kanagawa 212-0016, Japan. Email. [email protected]Search for more papers by this authorSyunichi Odawara, Syunichi Odawara Departments of Gastroenterology, Jikei Kashiwa Hospital, Kashiwa, Chiba, JapanSearch for more papers by this authorShunpei Fukuda, Shunpei Fukuda Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Fukuoka, JapanSearch for more papers by this authorTakashi Hashimoto, Takashi Hashimoto Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Fukuoka, JapanSearch for more papers by this author First published: 20 August 2012 https://doi.org/10.1111/j.1346-8138.2012.01645.xCitations: 12Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Egan CA, Lazarova Z, Darling TN, Yee C, Yancey KB. Anti-epiligrin cicatricial pemphigoid. Medicine 2003; 82: 177–186. 2Demitsu T, Yoneda K, Iida E et al. A case of mucous membrane pemphigoid with IgG antibodies against all the alpha3, beta3 and gamma2 subunits of laminin-332 and BP180 C-terminal domain, associated with pancreatic cancer. Clin Exp Dermatol 2009; 34: e992–e994. 3Dainichi T, Hirakawa Y, Ishii N et al. Mucous membrane pemphigoid with autoantibodies to all the laminin 332 subunits and fatal outcome resulting from liver cirrhosis and hepatocellular carcinoma. J Am Acad Dermatol 2011; 64: 1199–1200. 4Hashimoto T. Immunopathology of paraneoplastic pemphigus. Clin Dermatol 2001; 19: 675–682. Citing Literature Volume40, Issue1January 2013Pages 61-62 ReferencesRelatedInformation
Referência(s)